IRAK3 and bone sarcoma: To the best of our knowledge, its role in the bone sarcoma response to ICB has not yet been fully investigated, but, given the prevailing presence of macrophages and myeloid cells in bone sarcoma infiltrates, IRAK3 expression could be expected to have a role.